WO2011156663A1 - Method of treating a material using a sol-gel derived composition - Google Patents
Method of treating a material using a sol-gel derived composition Download PDFInfo
- Publication number
- WO2011156663A1 WO2011156663A1 PCT/US2011/039884 US2011039884W WO2011156663A1 WO 2011156663 A1 WO2011156663 A1 WO 2011156663A1 US 2011039884 W US2011039884 W US 2011039884W WO 2011156663 A1 WO2011156663 A1 WO 2011156663A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sol
- sorbate
- gel derived
- derived composition
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 146
- 238000000034 method Methods 0.000 title claims abstract description 46
- 239000000463 material Substances 0.000 title claims abstract description 26
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 claims abstract description 86
- 229940075554 sorbate Drugs 0.000 claims abstract description 86
- 238000002360 preparation method Methods 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 14
- 125000005375 organosiloxane group Chemical group 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000011068 loading method Methods 0.000 claims description 10
- 239000011159 matrix material Substances 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 6
- 239000004009 herbicide Substances 0.000 claims description 6
- 239000000575 pesticide Substances 0.000 claims description 6
- 239000002689 soil Substances 0.000 claims description 5
- 230000002363 herbicidal effect Effects 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000005949 Malathion Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical group CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 claims description 3
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 claims description 3
- 229960000453 malathion Drugs 0.000 claims description 3
- 229920001184 polypeptide Polymers 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000003963 dichloro group Chemical group Cl* 0.000 claims 1
- 239000000499 gel Substances 0.000 description 74
- 239000003814 drug Substances 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- -1 polysiloxanes Polymers 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000012385 systemic delivery Methods 0.000 description 4
- 238000012384 transportation and delivery Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000013043 chemical agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000206576 Chondrus Species 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
- C01B33/145—Preparation of hydroorganosols, organosols or dispersions in an organic medium
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
- A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/12—Powders or granules
Definitions
- the present invention relates generally to the chemical arts. More particularly, the invention relates to a method for the treating a material using a sol-gel controlled release of a sorbate, such as a pesticide, a herbicide or a pharmaceutical substance .
- a sorbate such as a pesticide, a herbicide or a pharmaceutical substance .
- a method and system that includes treating a material by applying a sol-gel derived composition loaded with a first sorbate under conditions effective to treat the material with the first sorbate.
- the sol-gel derived composition is substantially completely loaded with the sorbate and, in some aspects, the sol-gel derived composition is partially loaded with the sorbate.
- the sol-gci. derived com osition is an aromatically- bridged, organosiloxane sol-gel derived composition containing a plurality of alkylsiloxy substituents.
- the sol-gel derived composition is an aromaticaliy- bridged, organosiloxaiie sol-ge] derived composition containing a plurality of alkylsiloxy snbstituents and a cosmetically acceptable carrier.
- the first sorbate is biologically active. And is some such embodiments, the first sorbate is a pesticide, a herbicide or a pharmaceutical. In some such embodiments, the first sorbate is atrazuie, 2,4-dichiorophcnoxyacetic acid, malathion, dicWorodiphenyltrichloroetbane, impramiiie, a vitamin or a polypeptide,
- the loading density of the sorbate in the sol-gel derived composition ia from about 0.005 to about 5 gram sorbate per gram of the sol-gci derived composition. And in some aspects, the loading density of the sorbate in the sol-gel derived composition is from about 0.005 to about 5 gram sorbate per gram of the sol-gel derived composition.
- the method additionally includes applying a second sorbate after application of the first sorbate.
- the second sorbate is a water soluble organic liquid and, in some of these embodiments, the second sorbate is etiianol.
- the soi-gel derived composition is applied to a plant or an animal. And, in some embodiments, the sol-gel derived composition is applied to a human.
- the sol-gel derived composition is applied to a soil. And, in some, embodiments, an unloaded sol-gci derived composition is applied along with die loaded sol-gel derived composition. In some of these embodiments, the sol-gel derived composition includes inert particles having a diameter of from about 5 to about 20 DID. In some of these embodiments, the inert particle is magnetic and in some embodiments, the sol gel-derived composition containing magnetic panicles is removed from the treated material using a magnetic device.
- sol-gel derived composition is formulated with a non-liquid pharmaceutically effective carrier or a cosmetically acceptable carrier.
- sorbate means an organic compound that is taken up by the sol-gel derived compositions whether by adsorption, absorption, or a combination thereof.
- swellable means an increase of at least 1.5 times the volume of the sol-gel derived composition , when placed in excess sorbate compared to the vohime when dry.
- nanoparticle means a particle sized between about 2 and about 500 nanometers in one dimension.
- the sol -gel derived composition is swellable to at least 1 ,5 limes its volume, when dry, in acetone.
- Preferred sol-gei derived compositions are swellable to at least two times their ori inal volume, more preferably at least five times their original volume, and in some embodiments tip to about eight to ten ti mes their original volume.
- the swelling of the sol-gel derived composition and the sorption of the first sorbatc are driven by the release of stored tensile force rather than, by chemical reaction.
- the sol-gel derived composition is a porous, aiOmati cully- bridged, oi'ganosi loxane soi-gel derived composition containing a lurarity of alky) siJoxy substituents.
- the sol-gel derived composition contains a plurality of flexibly tethered and interconnected organosiloxane particles having diameters on the nanometer scale.
- the organosiloxane nanoparticles form a disorganized porous matrix defined by a plurality of cross-linked aromatic si!oxarres.
- the porous, aromatically bridged, organosiloxane sol-gel derived compositions contains a plurality of polysiloxanes that include an aromatic bridging group flexibly linking the silicon atoms of the polysiloxanes.
- Such organosiloxane nanoparticles have a multilayer configuration comprising a hydrophilic inner layer and a. hydrophobic, aromatic-rich outer layer.
- sol-gel derived compositions useful in accordance with the inventive method is disclosed in U .S. Pat. No. 7,790, 830 which patent is herein incorporated by reference.
- a suitable swellable sol-gel derived composition is Osorb® swellable sol-gel derived, composition available from ABS Materials, Wooster, Ohio.
- the porous, swellable sol-gel derived compositions is loaded with a first sorbate. It is an advantage of the invention that a wide variety of sorbates can be used.
- the sorbate is biologically active.
- Representative biologically active sorbates include, but are not limited to, pesticides, herbicides, such as atrazine, 2.4- dichlorophenoxyacetic acid, malathion, and dichlorodiplienyltrichloroelhane and pharmaceuticals, including drags such as impra ine, vitamins and pol peptides.
- the sol-gel . derived compositions are loaded with a first sorbate using any suitable method.
- the sol-gel derived composition can be contacted with the first sorbate under conditions sufficient to cause the sol-gel derived composition to sorb the sorbate.
- a nonvolatile first sorbate such as impramiiie.can be mixed with a volatile second sorbate, such as etbanol or a mixture of ethanol and dichloromethane, where the second sorbate is chosen because of its effectiveness in swelling the sol-gel derived composition .
- the sol-gel derived composition is contacted with the mixture, the mixture is healed, for example up to about 180° F (the decomposition temperature of the sol-gel derived composition ⁇ to remove the volatile second sorbate and produce a sol-gel derived composition loaded with (he first sorbate.
- the sol-gel derived composition is contacted with an aqueous solution containing a water soluble first sorbate, such as atrazine.
- the sol-gel derived composition is first swo llen with a sorbate and the sorbate is excha ged for a first water soluble sorbate by rinsing the swollen sol-gel derived composition with an aqueous solution containing the water-solubl sorbate.
- the loading density of the first sorbate in the sol-gel derived composition depends on the required concentration, application time and physical characteristics of the sorbate. The particular loading density for a speci fic application can be readily determined by one skilled in the art without undue experimentation.
- the loading density of the sorbate in tire sol-gel derived composition is from about 0.005 to about 5 gram sorbate per gram of the sol-gel derived composition.
- the loading density of the sorbate in the sol-gel derived composition is from about 0.01 to about 1 gram sorbate per gram of the sol-gel derived composition.
- the sol-gel derived composition is completely loaded with the first sorbate, I.e., the sol-gel derived composition has been treated under conditions such that substantially no additional sorbate can be sorbed by the sol-gel derived composition .
- the sol-gel derived composition is only partially loaded with the first sorbate.
- the sol-gel derived composition can be used in any suitable form, including in powder or pellet forms.
- Useful polymeric binders include microcrystalline cellulose and elast meric polymers.
- Preferred elastomeric polymers have a glass transition temperature below about 1 50 C, the temperature at which the sensor material begins to decompose.
- polystyrene and is a currently most preferred elastomeric polymer binder are described in U.S. Patent Nos.
- Pellets can be formed in any desired shape and size suitable for their desired application.
- the sol-gel derived, composition are appl ied, by any suitable method.
- the affinity of the sol-gel derived composition for the sorbate then provides for the slow desorption of the sorbate from the sol-gel derived composition at a . measured rate.
- Other factors diat can be used to influence the rate of release include the concentration griidient and die size of the sorbate.
- the material is treated with a second sorbate.
- Suitable second sorbates include, without limitation, water soluble organic liquids, such as ethanol. Sufficient second sorbate is applied to cause the sol-gel derived composition to swell and thus increase the rate of desorption of the first sorbate.
- both loaded and unloaded sol-gel derived composition arc- applied to the material.
- the unloaded sol-gel derived composition can be applied to an area different than the area where the loaded, sol-gel derived composition is applied, e.g. an area where no treatment is desired.
- tire sorbate is released from the loaded sol-gel derived composition , it is sorbed by the unloaded sohscl derived composition , thus providing control not only over the rate but the area of application of the sorbate.
- the sol-gel derived composition can additionally include inert particles having a diameter of from about 5 to about 20 ran. The particles can be chosen to increase the density of the sol-gel derived composition , thus, inhibiting the travel of the sol-gel derived composition in high winds or heavy rain.
- the inert particles are made of a magnetic material, such as metallic iron or magnetite, it is an advantage of sol-gel derived composition containing such magnetic particles that they can be readily removed from a material, once treatment is completed, using a magnetic device.
- Representative formulations containing the sorbate loaded sol-gel derived composition include, but are not limited, cosmetics, cleansers (e.g., skin cleansers), and medicaments, including pharmaceuticals in the form of tablets, capsules, ointments, or the like.
- Cosmetic formulations according to the invention can be contained in a wide variety of cosmetic preparations.
- Representative formulations include, but are not limited to, skin-care preparations, e.g. skin emulsions, multi-emulsions or skin oils and body powders; cosmetic personal care preparations, e.g. facial make-up in the form of lipsticks, lip gloss, eye shadow, liquid make-up, day creams or powders, facial lotions, creams and powders (loose or pressed); and light-protective preparations, such as sun tan lotions, creams and oils, sun blocks and pretann g preparations.
- skin-care preparations e.g. skin emulsions, multi-emulsions or skin oils and body powders
- cosmetic personal care preparations e.g. facial make-up in the form of lipsticks, lip gloss, eye shadow, liquid make-up, day creams or powders, facial lotions, creams and powders (loose or pressed)
- light-protective preparations such as sun
- compositions according to the invention comprise a l iquid or non liquid cosmetically acceptable carrier to act as a diluent, dispersant or vehicle for the sorbate- Ioaded sol-gei derived composition . so as to facilitate- its distribution when the composition is applied to the skin.
- Carriers other than or in addition to water can include liquid or solid emollients, solvents, humectants, thi ckeners and powders.
- Particularly suitable non aqueous carriers include polydimethyi, si!oxane and/or po!ydimethyl phenyl siloxaiie.
- Such formulations can additional ly include colorants, sequestering agents, thickening or solidifying (consistency regulating) agents, emollients.
- UV absorbers, skin- protective agents, antioxidants find preservatives..
- the sol-gel derived composition is formulated in at least one liquid or non liquid pharmaceutically acceptable carrier.
- the sol-gel derived composition is formulated in at least one liquid or non liquid pharmaceutically acceptable carrier.
- pharmaceutically acceptable carrier encompasses any of the standard pharmaceutical carriers known to those of skill in. the art.
- Pharmaceutically acceptable carriers include. solveni(s), vehicle(s), adjuvants), excipient(s), bt.nder(s), thickener(s), suspending. agent(s), or filler substance(s) thai are known to the skilled artisan suitable for administration to human and/or animals.
- Other useful carriers include gum acacia, agar, petrolatum, lanolin, dimethyl sulfoxide (DM.SO), normal saline ( S).
- PBS phosphate buffered saline
- uctoxvnol oleyl alcohol polyvinyl alcohol, povidone, propylene glycol raonostearate, sodium laiiryl sulfate, sorbitan esters, stearyl alcohol, tragacanth, xanthan gum, chondrus, glycerin, trolami te, avocado oil, almond oil, coconut oil. coconut butter, propylene glycol, ethyl alcohol, malt, and malt extract.
- Medicares include medicaments taken into the bodies of humans or non-human vertebrate animals, or applied topically thereto, by a delivery- system.
- a medica ent is a therapeuti c agent or substance, such as a drug, medicine, irrigaol, bandage, or other medical or dental device, that promotes recovery from injury or ailment or prevents or alleviates the symptoms of disease.
- Medicaments containing the sorbats-ioadel sol-gel derived composition can be formulated for any suitable systemic or non-systemic delivery system, including delivery systems for oral, enteral, or parenteral delivery routes include tablets, troches, lo enges, aqueous or oily suspensions, dispersible powders or granules, emulsions, hard or soft capsules. syrups, beverages, el ixirs or enteral formulas, lavage or enema solutions, adhesive patches, infusions, injectates, intravenous drips, inhalants, or implants. Delivery systems also include topical creams, ge!s, suppositories, or ointments for non-systemic localized deiivery or systemic delivery vi a the blood stream.
- Systemic- delivery systems that are contemplated by the present invention include, but are not limited to, implant; adhesive transdermal patches; topical creams, gels or oi tments for transdermal delivery; trausmucosal delivery matiiccs or suppositories or gels. It is contemplated that the compositions of the present invention are formulated to deliver an effective amount of the sorbaie by these or any other pharmaceutically acceptable systemic delivery system.
Abstract
Disclosed is a method and system that includes treating a material by applying a sol-gel derived composition loaded with a first sorbate under conditions effective to treat the material with the first sorbate.
Description
METHOD OF TREATING A MATERIAL USING
A SOL-GEL DERIVED COMPOSITION
Cross Reference to Related Application
This application claims the benefit of Provisional Patent Application Nos.
1/353,417, filed June 10, 2011 and 61/356,094, filed June 18, 2010.
Background of the Invention
1. Field of the Invention
The present invention relates generally to the chemical arts. More particularly, the invention relates to a method for the treating a material using a sol-gel controlled release of a sorbate, such as a pesticide, a herbicide or a pharmaceutical substance .
2. Discussion of the Related Art
Millions of pounds of chemical agents, including biologically active agents, such as pesticides , herbicides and pharmaceuticals are applied each year to mitigate damage lo crops and to promote animal and human health. Methods of application often lead to the tire chemical agent entering the surrounding environment through water run-off, evaporation, sublimation or tarongh human animal excrement. Consequently, there is a definite need for a method of controlling the rate of release of such chemical agents in order to prevent or minimize such unwanted effects.
Summary of the Invention
Now in accordance with the invention there has been found a method and system that meets these needs and provides additional advantages. Disclosed is a method and system that includes treating a material by applying a sol-gel derived composition loaded with a first sorbate under conditions effective to treat the material with the first sorbate. In some aspects , the sol-gel derived composition is substantially completely loaded with the sorbate and, in some aspects, the sol-gel derived composition is partially loaded with the sorbate.
In some aspects, the sol-gci. derived com osition is an aromatically- bridged, organosiloxane sol-gel derived composition containing a plurality of alkylsiloxy substituents. And in some aspects, the sol-gel derived composition is an aromaticaliy- bridged, organosiloxaiie sol-ge] derived composition containing a plurality of alkylsiloxy snbstituents and a cosmetically acceptable carrier.
In some embodiments, the first sorbate is biologically active. And is some such embodiments, the first sorbate is a pesticide, a herbicide or a pharmaceutical. In some such embodiments, the first sorbate is atrazuie, 2,4-dichiorophcnoxyacetic acid, malathion, dicWorodiphenyltrichloroetbane, impramiiie, a vitamin or a polypeptide,
In some aspects, the loading density of the sorbate in the sol-gel derived composition ia from about 0.005 to about 5 gram sorbate per gram of the sol-gci derived composition. And in some aspects, the loading density of the sorbate in the sol-gel derived composition is from about 0.005 to about 5 gram sorbate per gram of the sol-gel derived composition.
In some embodiments, the method additionally includes applying a second sorbate after application of the first sorbate. in some of these embodiments, the second sorbate is a water soluble organic liquid and, in some of these embodiments, the second sorbate is etiianol.
Tn some embodiments, the soi-gel derived composition is applied to a plant or an animal. And, in some embodiments, the sol-gel derived composition is applied to a human.
In some embodiments, the sol-gel derived composition is applied to a soil. And, in some, embodiments, an unloaded sol-gci derived composition is applied along with die loaded sol-gel derived composition. In some of these embodiments, the sol-gel derived composition includes inert particles having a diameter of from about 5 to about 20 DID. In some of these embodiments, the inert particle is magnetic and in some
embodiments, the sol gel-derived composition containing magnetic panicles is removed from the treated material using a magnetic device.
Also disclosed area skin-care preparations, personal care preparations, light- protective preparations, containing a sol-gel derived composition hi some aspects, the sol-gel derived composition is formulated with a non-liquid pharmaceutically effective carrier or a cosmetically acceptable carrier.
Detailed Description of the Preferred Embodiments
Particular embodiments of the invention are described below in considerable detail for the purpose of illustrating its principles and operation. However, various modifications may be made, and the scope of the invention is not limited to the exemplary embodiments described below.
■Unless otherwise defined, ail technical terms used, herein have the same meani ng as commonly understood by one of ordinary skill in the art to which the present invention pertains.
As used herein, the term "sorbate" means an organic compound that is taken up by the sol-gel derived compositions whether by adsorption, absorption, or a combination thereof.
As used herein, "swellable" means an increase of at least 1.5 times the volume of the sol-gel derived composition , when placed in excess sorbate compared to the vohime when dry.
As used herein, "nanoparticle" means a particle sized between about 2 and about 500 nanometers in one dimension.
In accordance with the invention, there has been discovered a novel method for treating a material by applying a sol-gel derived composition loaded with a first sorbate.
In some embodiments, the sol -gel derived composition is swellable to at least 1 ,5 limes its volume, when dry, in acetone. Preferred sol-gei derived compositions are swellable to at least two times their ori inal volume, more preferably at least five times their original volume, and in some embodiments tip to about eight to ten ti mes their original volume. The swelling of the sol-gel derived composition and the sorption of the first sorbatc are driven by the release of stored tensile force rather than, by chemical reaction.
In some embodiments, the sol-gel derived composition is a porous, aiOmati cully- bridged, oi'ganosi loxane soi-gel derived composition containing a lurarity of alky) siJoxy substituents. In such, embodiments, the sol-gel derived composition contains a plurality of flexibly tethered and interconnected organosiloxane particles having diameters on the nanometer scale. The organosiloxane nanoparticles form a disorganized porous matrix defined by a plurality of cross-linked aromatic si!oxarres.
The porous, aromatically bridged, organosiloxane sol-gel derived compositions contains a plurality of polysiloxanes that include an aromatic bridging group flexibly linking the silicon atoms of the polysiloxanes. Such organosiloxane nanoparticles have a multilayer configuration comprising a hydrophilic inner layer and a. hydrophobic, aromatic-rich outer layer.
The preparation of sol-gel derived compositions useful in accordance with the inventive method is disclosed in U .S. Pat. No. 7,790, 830 which patent is herein incorporated by reference. A suitable swellable sol-gel derived composition is Osorb® swellable sol-gel derived, composition available from ABS Materials, Wooster, Ohio.
The porous, swellable sol-gel derived compositions is loaded with a first sorbate. It is an advantage of the invention that a wide variety of sorbates can be used. In some embodiments, the sorbate is biologically active. Representative biologically active sorbates include, but are not limited to, pesticides, herbicides, such as atrazine, 2.4- dichlorophenoxyacetic acid, malathion, and dichlorodiplienyltrichloroelhane and pharmaceuticals, including drags such as impra ine, vitamins and pol peptides.
The sol-gel. derived compositions are loaded with a first sorbate using any suitable method. For example, the sol-gel derived composition can be contacted with the first sorbate under conditions sufficient to cause the sol-gel derived composition to sorb the sorbate. In an alternative embodiment, a nonvolatile first sorbate , such as impramiiie.can be mixed with a volatile second sorbate, such as etbanol or a mixture of ethanol and dichloromethane, where the second sorbate is chosen because of its effectiveness in swelling the sol-gel derived composition . The sol-gel derived composition is contacted with the mixture, the mixture is healed, for example up to about 180° F (the decomposition temperature of the sol-gel derived composition \ to remove the volatile second sorbate and produce a sol-gel derived composition loaded with (he first sorbate. In another alternative embodiment, the sol-gel derived composition is contacted with an aqueous solution containing a water soluble first sorbate, such as atrazine. In yet another alternative embodiment, the sol-gel derived composition is first swo llen with a sorbate and the sorbate is excha ged for a first water soluble sorbate by rinsing the swollen sol-gel derived composition with an aqueous solution containing the water-solubl sorbate.
The loading density of the first sorbate in the sol-gel derived composition depends on the required concentration, application time and physical characteristics of the sorbate. The particular loading density for a speci fic application can be readily determined by one skilled in the art without undue experimentation. In some embodiments, the loading density of the sorbate in tire sol-gel derived composition is from about 0.005 to about 5 gram sorbate per gram of the sol-gel derived composition. And in some embodiments, the loading density of the sorbate in the sol-gel derived composition is from about 0.01 to about 1 gram sorbate per gram of the sol-gel derived composition.
La some embodiments, the sol-gel derived composition is completely loaded with the first sorbate, I.e., the sol-gel derived composition has been treated under conditions such that substantially no additional sorbate can be sorbed by the sol-gel derived composition . In other embodiments, the sol-gel derived composition is only partially loaded with the first sorbate. When a sol-gel derived composition partially loaded with a
first sorbate is subsequently contacted with a second sorbate, the sol-gel derived composition swells thus more quickly releasing ihe first sorbate.
The sol-gel derived composition can be used in any suitable form, including in powder or pellet forms. In some embodiments and in particular those embodiments where the sol-gel derived composition is in pellet formt the porous sweilable sol-gel derived composition is combined with a binder, Useful polymeric binders include microcrystalline cellulose and elast meric polymers. Preferred elastomeric polymers have a glass transition temperature below about 1 50 C, the temperature at which the sensor material begins to decompose. For. example, polystyrene and is a currently most preferred elastomeric polymer binder. Other suitable thermoplastic elastomers are described in U.S. Patent Nos. 7,834,093, 7,799,873, 7,799,868, 7,799,869, 7,790,805, 7,786,206, 7,776,968, 7.771 ,627, 7,744,781 , 7,737,206, 7,655,719, 7,462,309, 6,596,792, 6, 1 62,849, 5,194,480, 7,837,90 k 7,815 ,998, 7,645,399, 7,608,342,
7,550,097, 7,402,616, 6,720,369, 4,634,730, 7,834,093 , 7,799,873, 7,799,868, 7,799,869, 7,790,805, 7,786,206, 7,776,968, 7,771 ,627, 7,744,781, 7,737,206 which patents are herein incorporated by reference. Pellets can be formed in any desired shape and size suitable for their desired application.
It is an advantage of the inventive method, that it is useful in treating a wide variety of materials, including, without limitation, soil, plants and animals, including mammals, and humans.
The sol-gel derived, composition are appl ied, by any suitable method. The affinity of the sol-gel derived composition for the sorbate then provides for the slow desorption of the sorbate from the sol-gel derived composition at a . measured rate. Other factors diat can be used to influence the rate of release include the concentration griidient and die size of the sorbate. hi some embodiments, after application of the sol-gel derived composition partially loaded with the first sorbate to the material, the material is treated with a second sorbate. Suitable second sorbates include, without limitation, water soluble organic
liquids, such as ethanol. Sufficient second sorbate is applied to cause the sol-gel derived composition to swell and thus increase the rate of desorption of the first sorbate. in sortie embodiments, both loaded and unloaded sol-gel derived composition arc- applied to the material. For example, the unloaded sol-gel derived composition can be applied to an area different than the area where the loaded, sol-gel derived composition is applied, e.g. an area where no treatment is desired. As tire sorbate is released from the loaded sol-gel derived composition , it is sorbed by the unloaded sohscl derived composition , thus providing control not only over the rate but the area of application of the sorbate.
In some embodiments, especially in those embodiments where the sol-gel derived composition is applied as an amendment to soil, the sol-gel derived composition can additionally include inert particles having a diameter of from about 5 to about 20 ran. The particles can be chosen to increase the density of the sol-gel derived composition , thus, inhibiting the travel of the sol-gel derived composition in high winds or heavy rain.
And in some of these embodiments, the inert particles are made of a magnetic material, such as metallic iron or magnetite, it is an advantage of sol-gel derived composition containing such magnetic particles that they can be readily removed from a material, once treatment is completed, using a magnetic device.
Representative formulations containing the sorbate loaded sol-gel derived composition , include, but are not limited, cosmetics, cleansers (e.g., skin cleansers), and medicaments, including pharmaceuticals in the form of tablets, capsules, ointments, or the like.
Cosmetic formulations according to the invention can be contained in a wide variety of cosmetic preparations. Representative formulations include, but are not limited to, skin-care preparations, e.g. skin emulsions, multi-emulsions or skin oils and body powders; cosmetic personal care preparations, e.g. facial make-up in the form of lipsticks, lip gloss, eye shadow, liquid make-up, day creams or powders, facial lotions, creams and
powders (loose or pressed); and light-protective preparations, such as sun tan lotions, creams and oils, sun blocks and pretann g preparations.
The compositions according to the invention comprise a l iquid or non liquid cosmetically acceptable carrier to act as a diluent, dispersant or vehicle for the sorbate- Ioaded sol-gei derived composition . so as to facilitate- its distribution when the composition is applied to the skin. Carriers other than or in addition to water can include liquid or solid emollients, solvents, humectants, thi ckeners and powders. Particularly suitable non aqueous carriers include polydimethyi, si!oxane and/or po!ydimethyl phenyl siloxaiie. Such formulations can additional ly include colorants, sequestering agents, thickening or solidifying (consistency regulating) agents, emollients. UV absorbers, skin- protective agents, antioxidants find preservatives..
In some embodiments .the sol-gel derived composition is formulated in at least one liquid or non liquid pharmaceutically acceptable carrier. As used herein,
"pharmaceutically acceptable carrier" encompasses any of the standard pharmaceutical carriers known to those of skill in. the art. Pharmaceutically acceptable carriers include. solveni(s), vehicle(s), adjuvants), excipient(s), bt.nder(s), thickener(s), suspending. agent(s), or filler substance(s) thai are known to the skilled artisan suitable for administration to human and/or animals. Other useful carriers include gum acacia, agar, petrolatum, lanolin, dimethyl sulfoxide (DM.SO), normal saline ( S). phosphate buffered saline (PBS)> sodium alginate, bentoiiite, carbomer, carboxy ethyl cellulose, carrageenan, powdered cellulose, cholesterol, gelatin, hydroxyetbyl cellulose, hydroxypropyl cellulose, hydroxypropyl metliy!cellulose, mcdiylcdlul ose. uctoxvnol oleyl alcohol, polyvinyl alcohol, povidone, propylene glycol raonostearate, sodium laiiryl sulfate, sorbitan esters, stearyl alcohol, tragacanth, xanthan gum, chondrus, glycerin, trolami te, avocado oil, almond oil, coconut oil. coconut butter, propylene glycol, ethyl alcohol, malt, and malt extract.
Medicares include medicaments taken into the bodies of humans or non-human vertebrate animals, or applied topically thereto, by a delivery- system. A medica ent is a therapeuti c agent or substance, such as a drug, medicine, irrigaol, bandage, or other
medical or dental device, that promotes recovery from injury or ailment or prevents or alleviates the symptoms of disease. Medicaments containing the sorbats-ioadel sol-gel derived composition can be formulated for any suitable systemic or non-systemic delivery system, including delivery systems for oral, enteral, or parenteral delivery routes include tablets, troches, lo enges, aqueous or oily suspensions, dispersible powders or granules, emulsions, hard or soft capsules. syrups, beverages, el ixirs or enteral formulas, lavage or enema solutions, adhesive patches, infusions, injectates, intravenous drips, inhalants, or implants. Delivery systems also include topical creams, ge!s, suppositories, or ointments for non-systemic localized deiivery or systemic delivery vi a the blood stream.
Systemic- delivery systems that are contemplated by the present invention include, but are not limited to, implant; adhesive transdermal patches; topical creams, gels or oi tments for transdermal delivery; trausmucosal delivery matiiccs or suppositories or gels. It is contemplated that the compositions of the present invention are formulated to deliver an effective amount of the sorbaie by these or any other pharmaceutically acceptable systemic delivery system.
From the above description of the invention, those skilled in the art will perceive improvements, changes and modifications. For example, one skilled in the art will appreciate that other agents and materials, such as charged organic polymers (e.g., polyethyleneimine) and'or organosilica nanoparticJes having different surface chemistries can be included in the sensor material to facil itate detection of sotbatcs. Such improvements, changes, and modifications are within the skill of the art and are intended to be covered by the appended claims,
Claims
1. A method of treating a material comprising the step of
applying an aromatically- bridged, organosiloxane sol-gel derived composition, containing a plurality of a11cy3.si.loxy substituents loaded with a first sorbate under conditions effective to treat the material with the Erst sorbate.
2. The method of claim 2 wherein the first sorbate is biologically active.
3. The method of claim 3 wherein the first sorbate is a pesticide, a herbicide or a pharmaceutical.
4. The method of claim 3 wherem the first sorbate is atrazme, 2,4- dichlorophenoxyacetie acid, maiathion, dichlorodiphenyltrichloroelliane, npraminc. a vitamin or a polypeptide.
5. The method of claim 1 wherein the loading density of the sorbate in the sol-gel derived composition is from about 0.005 to about 5 gram sorbate per gram of the so!-gel derived composition.
6. The method of claim J wherein the loading density of the sorbale in the so!-gel derived composition is from about 0.005 to about 5 gram sorbate per gram of the sol-gel derived composition.
7. The method of claim 1 wherein the soi-gel derived composition is substantially completely loaded with the .sorbate.
8. The method of claim 1 wherein the sol-gei derived composition is partially loaded with the sorbate.
9. The method of claim 8 further comprising applying a second sorbate after application of the first sorbate.
10. The method of claim 9 wherein the second sorbaie i s a water soluble organic liquid.
11. The method of claim ] 0 wherein the second sorbate is ethianol
12. The method of claim 1 wherein the sol-gel derived composition is applied to a plant or an animal.
13. The method of claim 1 wherein the sol-gel derived composition is applied to a human.
14. The method of claim 1 wherein the so I- gel derived composition is applied to a soil.
15. The method of claim 1 further comprising applying an unloaded aromatkaliy- bridged, organosiloxane sol-gel derived composition containing a plurality of alkylsiloxy substituents to the material along widi tire loaded sol-gel derived composition ..
16. The method of claim 1 wherein die sol-gel derived composition includes inert particles having a diameter of from about 5 to about 20 rim.
17. T e method of claim 16 where the inert particle is magnetic.
1 . The method of claim 17 further comprising removing the sol gel-derived compositio from the treated material with a magnetic device.
19. A composition of matter comprising:
an aromatically- bridged, organosiloxane sol-gel derived composition containing a plurality of alkylsiloxy substituents and a cosmetically acceptable carrier.
-I I -
20. Λ composition of matter comprising:
a sliin-care preparation, personal care preparation or light-protective preparation containing an aromaticaily- bridged, organosiloxane sol-gel derived composition containing a plurality of alkylsiioxy substituents.
21. A composition of matter comprising:
an aromaticaily- bridged, organosiloxane sol-gel derived composition containing a plurality of alkyl siioxy substituents and a non-liquid pharmaceutically effective carrier.
22. A composition of matter comprising:
a sorbatc-loaded aromaticaily- bridged, organosiloxane sol-gel derived composition containing a plurality of alkylsiioxy substituents and a cosmetically acceptable carrier.
23. A composition of matter comprising:
a skin-care preparation, personal care preparation or light-protective preparations containing a sorbate loaded arornatjcally- bridged, organosiloxane sol-gel derived composition containing a plurality of alfcylsilcwty substitucnts.
24. A composition of matter compri sing:
an aromaticaily- bridgsd. organosiloxane sol-gel derived composition containing a plurality of alkylsiioxy substitucnts loaded with a first sorbate and a non-liquid pharmaceutically effective carrier.
'
25. A method of treating a material compri sing the step of
applying a sorbatc-loaded sol-gel derived composition havi ng a porous matrix, the sol-gel derived composition swellable to at least 1.5 times its volume, loaded with a first sorbate, under conditions effective to treat the material with the first soibate,
26. The method of claim 25 wherein the first sorbate is biologically active.
27. The method of claim 26 wherein the first sorbate is a pesticide, a herbicide or a pharmaceutical
28. The metliod of claim 27 wherein the fi rst sorbate is atrazine. 2;4- dichloropheiioxyacetic acid, malathion, dichloro iphenyttrichioroelhaae: unpnur.ine, a vitamin or a polypeptide.
29. The metliod of claim 25 wherein the loading density of the sorbate in the sol-gel derived composition is from about 0.005 to about 5 gram sorbate per gram of the sol-gel derived composition .
30. The method of claim 25 wherein the loading density of the sor te in the sol-gel derived composition is from about 0.005 to about 5 gram sorbate per gram of die sol-gel derived composition.
31. The metliod of claim 25 wherein the sol-gel derived composition is substantially completely loaded with the sorbate,
32. The method of claim 25 wherein the sol-gpl deri ved com osition is partially loaded with the sorbate.
33. The metliod of claim 32 further comprisi ng ap lying a second sorbate after application of the first sorbate.
34. The method of claim 33 wherein the second sorbate is a water soluble organic liquid.
35. The method of claim 34 wherein the second sorbate is ethanol.
36. The method of claim 25 wherein the sol-gel derived composilioii is applied to a plant or an animal.
37. The method of claim 25 wherein the sol-gef derived composition is applied to a human.
38. The method of claim 25 wherein the sol-gc! derived composition i applied to a soil.
39. The method of claim 25 further comprising applying an unloaded aromaticall - bridged, organosiloxane sol-gel derived composition containing a plurality of alley! siloxy substituents to the material along with the loaded sol-gel derived composition ..
40. The method of claim 25 wherein the sol-gel derived composition 3 nc hides inert particles having a diameter of from about 5 to about 20 nm.
41 . The method of claim 40 where the inert particle is magnetic.
42. The method of claim 41 further comprising removing the sol gel-derived composition from the treated material with a magnetic device.
43. A composition of matter comprising:
a sol-gel derived composition having a porous matrix, the sol-gel derived composition swdiabie to at least 1.5 times its volume, and a cosmetically acceptable carrier.
44. A composition of matter comprising:
a skin-care preparation, personal care preparation or light-protective preparation containing a sol-gel derived composition having a porous matrix, the sol-ge! derived composition swellable to at least 1..5 times its volume.
45. A composition of matter comprising:
a soi-gel derived composition having a porous matrix, the sol-gel derived composition, swellable to at least 1.5 times its volume, and a non-liquid pharmaceutically effective carrier.
46. A composition of matter comprising:
a sorbate-ioaded soi-gel derived composition having a porous matrix, the sol-gel derived composition swellable to at least 1.5 times its volume, and a cosmetically acceptable carrier.
47. A composition of matter comprising:
a skin-care preparation, personal care preparation or light protecvive preparations containing a sorbate-ioaded sol-gel derived composition having a porous matrix, the sol- gel derived composition swellable to at least 1.5 times its volume.
48. A composition of matter comprising:
an aromatically- bridged, organosiloxanc sol-gel derived composition containing a sorbate-ioaded sol-gel derived composition having a porous matrix, tire sol-gel derived composition swellable to at ieast 1.5 times its volume, and a non-liquid pharmaceutically effective carrier.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35341710P | 2010-06-10 | 2010-06-10 | |
US61/353,417 | 2010-06-10 | ||
US35609410P | 2010-06-18 | 2010-06-18 | |
US61/356,094 | 2010-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011156663A1 true WO2011156663A1 (en) | 2011-12-15 |
Family
ID=44534599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/039884 WO2011156663A1 (en) | 2010-06-10 | 2011-06-09 | Method of treating a material using a sol-gel derived composition |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011156663A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2579793C1 (en) * | 2014-11-06 | 2016-04-10 | Государственное бюджетное учреждение Республики Башкортостан "Научно-исследовательский технологический институт гербицидов и регуляторов роста растений с опытно-экспериментальным производством Академии наук Республики Башкортостан" | Herbicidal composition in form of microemulsion concentrate |
Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634730A (en) | 1984-05-31 | 1987-01-06 | Gencorp Inc. | Carpet tiles |
US5194480A (en) | 1991-05-24 | 1993-03-16 | W. R. Grace & Co.-Conn. | Thermally conductive elastomer |
US6162849A (en) | 1999-01-11 | 2000-12-19 | Ferro Corporation | Thermally conductive thermoplastic |
US6596792B2 (en) | 1998-06-25 | 2003-07-22 | Caterpillar Inc | Tribological performance of thermoplastic composites via thermally conductive material and other fillers and a process for making the composite and molded articles of the same |
US6720369B2 (en) | 2000-11-15 | 2004-04-13 | Pku Pulverkautschuk Union Gmbh | Modified rubber powders comprising silicatic fillers prepared from precipitation suspensions, process for their preparation and their use |
US20050208087A1 (en) * | 2002-03-06 | 2005-09-22 | Konrad Kuerzinger | Modified oxidic nano-particle with hydrophobic inclusions, method for the production and use of said particle |
US20070112242A1 (en) * | 2005-09-30 | 2007-05-17 | The College Of Wooster | Swellable sol-gels, methods of making, and use thereof |
US7402616B2 (en) | 2004-09-30 | 2008-07-22 | Lifescan, Inc. | Fusible conductive ink for use in manufacturing microfluidic analytical systems |
US7462309B2 (en) | 2002-04-15 | 2008-12-09 | Cool Shield, Inc. | Method for making thermoplastic thermally-conductive interface articles |
US7550097B2 (en) | 2003-09-03 | 2009-06-23 | Momentive Performance Materials, Inc. | Thermal conductive material utilizing electrically conductive nanoparticles |
US7603342B2 (en) | 2003-08-29 | 2009-10-13 | Vortaloptics, Inc. | Method, device and software for querying and presenting search results |
US7645399B2 (en) | 2005-05-31 | 2010-01-12 | Xerox Corporation | Electroconductive composition |
US7655719B2 (en) | 2004-07-13 | 2010-02-02 | Cool Options, Inc. | Thermally conductive polymer compositions having moderate tensile and flexural properties |
US20100096334A1 (en) * | 2005-09-30 | 2010-04-22 | Absorbent Materials Company Llc | Swellable materials and methods of use |
US7737206B2 (en) | 2005-11-18 | 2010-06-15 | Exxonmobil Chemical Patents Inc. | Polyolefin composition with high filler loading capacity |
US7744781B2 (en) | 2006-08-16 | 2010-06-29 | Sumitomo Rubber Industries, Ltd. | Conductive thermoplastic elastomer composition, method of producing same, and molding |
US7771627B2 (en) | 2002-04-10 | 2010-08-10 | Fujikura Ltd. | Conductive composition |
US7776968B2 (en) | 2004-02-20 | 2010-08-17 | Riken Technos Corp. | Thermoplastic elastomer composition and thermoplastic resin composition using the same |
US7786206B2 (en) | 2005-01-18 | 2010-08-31 | Asahi Kasei Chemicals Corporation | Thermoplastic resin composition |
US7790805B2 (en) | 2002-11-29 | 2010-09-07 | Bayer Materialscience Ag | Impact-modified blends |
US7799868B2 (en) | 2006-02-22 | 2010-09-21 | Bayer Materialscience Llc | Flame retardant, impact resistant thermoplastic molding composition |
US7799873B2 (en) | 2005-05-10 | 2010-09-21 | The Yokohama Rubber Co., Ltd. | Thermoplastic elastomer composition |
US7799869B2 (en) | 2004-01-30 | 2010-09-21 | Kaneka Corporation | Thermoplastic elastomer composition and molded article |
US7815998B2 (en) | 2007-02-06 | 2010-10-19 | World Properties, Inc. | Conductive polymer foams, method of manufacture, and uses thereof |
US7834093B2 (en) | 2005-01-17 | 2010-11-16 | Polymersnet Co., Ltd. | Polyolefin-based thermoplastic polymer composition |
US7837901B2 (en) | 2005-06-27 | 2010-11-23 | E. I. Du Pont De Nemours And Company | Electrically conductive polymer compositions |
-
2011
- 2011-06-09 WO PCT/US2011/039884 patent/WO2011156663A1/en active Application Filing
Patent Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4634730A (en) | 1984-05-31 | 1987-01-06 | Gencorp Inc. | Carpet tiles |
US5194480A (en) | 1991-05-24 | 1993-03-16 | W. R. Grace & Co.-Conn. | Thermally conductive elastomer |
US6596792B2 (en) | 1998-06-25 | 2003-07-22 | Caterpillar Inc | Tribological performance of thermoplastic composites via thermally conductive material and other fillers and a process for making the composite and molded articles of the same |
US6162849A (en) | 1999-01-11 | 2000-12-19 | Ferro Corporation | Thermally conductive thermoplastic |
US6720369B2 (en) | 2000-11-15 | 2004-04-13 | Pku Pulverkautschuk Union Gmbh | Modified rubber powders comprising silicatic fillers prepared from precipitation suspensions, process for their preparation and their use |
US20050208087A1 (en) * | 2002-03-06 | 2005-09-22 | Konrad Kuerzinger | Modified oxidic nano-particle with hydrophobic inclusions, method for the production and use of said particle |
US7771627B2 (en) | 2002-04-10 | 2010-08-10 | Fujikura Ltd. | Conductive composition |
US7462309B2 (en) | 2002-04-15 | 2008-12-09 | Cool Shield, Inc. | Method for making thermoplastic thermally-conductive interface articles |
US7790805B2 (en) | 2002-11-29 | 2010-09-07 | Bayer Materialscience Ag | Impact-modified blends |
US7603342B2 (en) | 2003-08-29 | 2009-10-13 | Vortaloptics, Inc. | Method, device and software for querying and presenting search results |
US7550097B2 (en) | 2003-09-03 | 2009-06-23 | Momentive Performance Materials, Inc. | Thermal conductive material utilizing electrically conductive nanoparticles |
US7799869B2 (en) | 2004-01-30 | 2010-09-21 | Kaneka Corporation | Thermoplastic elastomer composition and molded article |
US7776968B2 (en) | 2004-02-20 | 2010-08-17 | Riken Technos Corp. | Thermoplastic elastomer composition and thermoplastic resin composition using the same |
US7655719B2 (en) | 2004-07-13 | 2010-02-02 | Cool Options, Inc. | Thermally conductive polymer compositions having moderate tensile and flexural properties |
US7402616B2 (en) | 2004-09-30 | 2008-07-22 | Lifescan, Inc. | Fusible conductive ink for use in manufacturing microfluidic analytical systems |
US7834093B2 (en) | 2005-01-17 | 2010-11-16 | Polymersnet Co., Ltd. | Polyolefin-based thermoplastic polymer composition |
US7786206B2 (en) | 2005-01-18 | 2010-08-31 | Asahi Kasei Chemicals Corporation | Thermoplastic resin composition |
US7799873B2 (en) | 2005-05-10 | 2010-09-21 | The Yokohama Rubber Co., Ltd. | Thermoplastic elastomer composition |
US7645399B2 (en) | 2005-05-31 | 2010-01-12 | Xerox Corporation | Electroconductive composition |
US7837901B2 (en) | 2005-06-27 | 2010-11-23 | E. I. Du Pont De Nemours And Company | Electrically conductive polymer compositions |
US7790830B2 (en) | 2005-09-30 | 2010-09-07 | Wootech, Ltd. | Swellable sol-gels, methods of making, and use thereof |
US20100096334A1 (en) * | 2005-09-30 | 2010-04-22 | Absorbent Materials Company Llc | Swellable materials and methods of use |
US20070112242A1 (en) * | 2005-09-30 | 2007-05-17 | The College Of Wooster | Swellable sol-gels, methods of making, and use thereof |
US7737206B2 (en) | 2005-11-18 | 2010-06-15 | Exxonmobil Chemical Patents Inc. | Polyolefin composition with high filler loading capacity |
US7799868B2 (en) | 2006-02-22 | 2010-09-21 | Bayer Materialscience Llc | Flame retardant, impact resistant thermoplastic molding composition |
US7744781B2 (en) | 2006-08-16 | 2010-06-29 | Sumitomo Rubber Industries, Ltd. | Conductive thermoplastic elastomer composition, method of producing same, and molding |
US7815998B2 (en) | 2007-02-06 | 2010-10-19 | World Properties, Inc. | Conductive polymer foams, method of manufacture, and uses thereof |
Non-Patent Citations (3)
Title |
---|
BOTTCHER H ET AL: "Sol-gel composite films with controlled release of biocides", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 60, no. 1, 28 June 1999 (1999-06-28), pages 57 - 65, XP004170491, ISSN: 0168-3659, DOI: 10.1016/S0168-3659(99)00053-X * |
GRAHAM A L ET AL: "Development and characterization ot molecularly imprinted sol-gel materials for the selective detection of DDT", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 74, no. 2, 15 January 2002 (2002-01-15), pages 458 - 467, XP008111923, ISSN: 0003-2700, [retrieved on 20011218], DOI: 10.1021/AC0106142 * |
PAUL L EDMISTON: "Pilot Scale Testing of Swellable Organo- Silica-Nanoparticle Composite Materials for the in situ and ex situ Remediation of Groundwater Contaminated with Chlorinated Organics", 13 May 2010 (2010-05-13), Federal Remediation Technologies Roundtable Meeting May 2010, Arlington (Va), U.S.A., pages 1 - 36, XP055006953, Retrieved from the Internet <URL:http://www.frtr.gov/pdf/meetings/may10/presentations/edmiston-presentation.pdf> [retrieved on 20110913] * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2579793C1 (en) * | 2014-11-06 | 2016-04-10 | Государственное бюджетное учреждение Республики Башкортостан "Научно-исследовательский технологический институт гербицидов и регуляторов роста растений с опытно-экспериментальным производством Академии наук Республики Башкортостан" | Herbicidal composition in form of microemulsion concentrate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Servatan et al. | Zeolites in drug delivery: Progress, challenges and opportunities | |
Kim et al. | Review of clay-drug hybrid materials for biomedical applications: Administration routes | |
US11110068B2 (en) | Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same | |
Jain et al. | Comparison of ciprofloxacin hydrochloride‐loaded protein, lipid, and chitosan nanoparticles for drug delivery | |
Abdelkader et al. | Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model | |
Kapileshwari et al. | Novel drug delivery system of luliconazole-Formulation and characterisation | |
García-Villén et al. | Clay minerals in drug delivery systems | |
Palanikumar et al. | Influence of particle size of nano zinc oxide on the controlled delivery of Amoxicillin | |
Abdullayev et al. | Halloysite for controllable loading and release | |
Ibrahim et al. | Synthesis of chitosan/diatomite composite as an advanced delivery system for ibuprofen drug; equilibrium studies and the release profile | |
El-Ela et al. | New approach in ulcer prevention and wound healing treatment using doxycycline and amoxicillin/LDH Nanocomposites | |
Pawar | Nanosponges: A novel drug delivery system | |
Deng et al. | Toward improvements for carrying capacity of the cyclodextrin-based nanosponges: recent progress from a material and drug delivery | |
Kumar et al. | Cyclodextrin nanosponges: a promising approach for modulating drug delivery | |
Joshi et al. | Fabrication and in-vivo evaluation of lipid nanocarriers based transdermal patch of colchicine | |
Luan et al. | Functional biomaterials for comprehensive periodontitis therapy | |
Thakker et al. | Inter-polymer complex microspheres of chitosan and cellulose acetate phthalate for oral delivery of 5-fluorouracil | |
US8563649B2 (en) | Method of treating a material using a sol-gel derived composition | |
Ward et al. | Halloysite nanoclay for controlled release applications | |
WO2011156663A1 (en) | Method of treating a material using a sol-gel derived composition | |
Bavya et al. | Synergistic treatment strategies to combat resistant bacterial infections using Schiff base modified nanoparticulate-hydrogel system | |
Raj et al. | Formulation and evaluation of coated microspheres for colon targeting | |
WO2016066864A1 (en) | Nanoparticles for the controlled release of active ingredients | |
Rawal et al. | Doxorubicin layer-by-layer nanoparticles for controlled delivery and effective treatment of pancreatic cancer | |
EP3373983A1 (en) | Multifunctional transdermal dressing for wounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11728730 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11728730 Country of ref document: EP Kind code of ref document: A1 |